ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Embecta Corporation

Embecta Corporation (EMBC)

14.25
0.17
(1.21%)
Closed November 02 4:00PM
14.25
0.00
(0.00%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
14.25
Bid
13.52
Ask
14.50
Volume
134,087
13.98 Day's Range 14.40
9.925 52 Week Range 19.79
Market Cap
Previous Close
14.08
Open
14.25
Last Trade Time
Financial Volume
$ 1,896,053
VWAP
14.1405
Average Volume (3m)
362,100
Shares Outstanding
57,701,830
Dividend Yield
4.21%
PE Ratio
11.68
Earnings Per Share (EPS)
1.22
Revenue
1.12B
Net Profit
70.4M

About Embecta Corporation

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others. Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Embecta Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker EMBC. The last closing price for Embecta was $14.08. Over the last year, Embecta shares have traded in a share price range of $ 9.925 to $ 19.79.

Embecta currently has 57,701,830 shares outstanding. The market capitalization of Embecta is $812.44 million. Embecta has a price to earnings ratio (PE ratio) of 11.68.

EMBC Latest News

embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes

While 9 out of 10 people with diabetes are living with T2D, many of the automated insulin delivery solutions currently on the market were designed for people living with T1D.300-unit insulin...

embecta to Participate in Investor Events

PARSIPPANY, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that...

Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results

PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and...

embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and...

US Futures Climb Following Thursday’s Rally, Oil Prices Steady

U.S. stock futures advanced in pre-market trading on Friday, extending the recovery seen on Thursday after Monday’s selloff. Despite recent gains, the S&P 500, Nasdaq, and Dow are still down...

Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company

Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company PR Newswire NEW YORK, July 29, 2024 Genpact's deep domain knowledge and data expertise enables embecta's vision to...

embecta to Report Fiscal Third Quarter 2024 Financial Results

PARSIPPANY, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.151.0638297872314.114.64512413.8216129914.21604584CS
40.816.0267857142913.4414.64512412.4227457513.49309475CS
12-2.24-13.583990297116.4917.3312.4236210014.73828366CS
264.0940.255905511810.1617.331040036313.93474033CS
52-0.8-5.3156146179415.0519.799.92543035614.75606434CS
156-18.11-55.964153275632.3636.649.92562927123.85198579CS
260-18.11-55.964153275632.3636.649.92562927123.85198579CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VSTEVast Renewable Ltd
$ 4.98
(149.00%)
68.46M
INVZWInnoviz Technologies Ltd
$ 0.096
(96.71%)
22.71k
CDXCChromaDex Corporation
$ 5.87
(68.19%)
37.58M
ATHAAthira Pharma Inc
$ 0.606
(41.56%)
236.07M
TILEInterface Inc
$ 23.24
(33.03%)
2.12M
EPIXESSA Pharma Inc
$ 1.45
(-72.12%)
34.3M
ELABElevai Labs Inc
$ 0.0288
(-51.19%)
202.28M
OSTOstin Technology Group Company Ltd
$ 0.275
(-45.00%)
2.27M
LXRXLexicon Pharmaceuticals Inc
$ 1.23
(-36.92%)
21M
VCIGVCI Global Ltd
$ 0.0583
(-27.58%)
26.57M
ATHAAthira Pharma Inc
$ 0.606
(41.56%)
239.63M
SQQQProShares UltraPro Short QQQ
$ 7.44
(-2.11%)
216.16M
NVDANVIDIA Corporation
$ 135.40
(1.99%)
209.27M
ELABElevai Labs Inc
$ 0.0288
(-51.19%)
202.28M
INTCIntel Corporation
$ 23.20
(7.81%)
173.47M

Your Recent History

Delayed Upgrade Clock